GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XORTX Therapeutics Inc (STU:ANUA) » Definitions » E10

XORTX Therapeutics (STU:ANUA) E10 : €-2.06 (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is XORTX Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

XORTX Therapeutics's adjusted earnings per share data for the three months ended in Sep. 2024 was €-0.180. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-2.06 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-14), XORTX Therapeutics's current stock price is €0.82. XORTX Therapeutics's E10 for the quarter that ended in Sep. 2024 was €-2.06. XORTX Therapeutics's Shiller PE Ratio of today is .


XORTX Therapeutics E10 Historical Data

The historical data trend for XORTX Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XORTX Therapeutics E10 Chart

XORTX Therapeutics Annual Data
Trend Feb15 Feb16 Feb17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only - - - - -

XORTX Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -2.00 -2.05 -2.06

Competitive Comparison of XORTX Therapeutics's E10

For the Biotechnology subindustry, XORTX Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


XORTX Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XORTX Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where XORTX Therapeutics's Shiller PE Ratio falls into.



XORTX Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, XORTX Therapeutics's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.18/127.2847*127.2847
=-0.180

Current CPI (Sep. 2024) = 127.2847.

XORTX Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201411 -0.054 99.078 -0.069
201502 -0.162 99.078 -0.208
201505 -0.761 100.263 -0.966
201508 -0.344 100.579 -0.435
201511 -0.736 100.421 -0.933
201602 0.019 100.421 0.024
201605 -0.224 101.765 -0.280
201608 -0.265 101.686 -0.332
201611 -0.271 101.607 -0.339
201702 -1.518 102.476 -1.886
201705 -0.167 103.108 -0.206
201708 -0.239 103.108 -0.295
201711 -0.138 103.740 -0.169
201803 -3.318 105.004 -4.022
201806 -0.300 105.557 -0.362
201809 -0.342 105.636 -0.412
201812 0.222 105.399 0.268
201903 -0.034 106.979 -0.040
201906 -0.176 107.690 -0.208
201909 -0.152 107.611 -0.180
201912 -0.026 107.769 -0.031
202003 -0.032 107.927 -0.038
202006 -0.687 108.401 -0.807
202009 -0.343 108.164 -0.404
202012 -0.384 108.559 -0.450
202103 -1.557 110.298 -1.797
202106 -0.120 111.720 -0.137
202109 -5.338 112.905 -6.018
202112 6.157 113.774 6.888
202203 -1.716 117.646 -1.857
202206 -0.766 120.806 -0.807
202209 -0.838 120.648 -0.884
202212 -1.567 120.964 -1.649
202303 -0.887 122.702 -0.920
202306 -0.785 124.203 -0.804
202309 -0.628 125.230 -0.638
202312 1.256 125.072 1.278
202403 -1.141 126.258 -1.150
202406 0.056 127.522 0.056
202409 -0.180 127.285 -0.180

Add all the adjusted EPS together and divide 10 will get our e10.


XORTX Therapeutics  (STU:ANUA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


XORTX Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of XORTX Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


XORTX Therapeutics Business Description

Traded in Other Exchanges
Address
3710 - 33rd Street NW, Calgary, AB, CAN, T2L 2M1
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

XORTX Therapeutics Headlines

No Headlines